STOCK TITAN

Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026

(Moderate)
(Positive)
Tags
earnings date

Rapid Micro Biosystems (Nasdaq: RPID) will release its second quarter 2026 financial results before the market opens on Friday, August 7, 2026. Management will host a webcast conference call at 8:30 a.m. ET, accessible via live audio webcast on the company’s website, with a replay available afterward.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market Context

Bain Capital Life Sciences Investors, LLC recorded 4,389,000 shares bought and 0 sold in the 90-day ...
Analysis

Bain Capital Life Sciences Investors, LLC recorded 4,389,000 shares bought and 0 sold in the 90-day insider context. That net-buying record adds context, while low short positioning remains a separate risk factor to watch.

Key Figures

Reporting period: Q2 2026 Results release date: August 7, 2026 Webcast time: 8:30 a.m. ET
3 metrics
Reporting period Q2 2026 Financial results announcement
Results release date August 7, 2026 Before market open
Webcast time 8:30 a.m. ET August 7, 2026

Previous Earnings date Reports

2 past events · Latest: May 06 (Neutral)
Same Type Pattern 2 events
Date Event Sentiment 24h Move Catalyst
May 06 Earnings date Neutral +1.2% Scheduled Q1 2026 results after market close with management webcast afterward
Feb 24 Earnings date Neutral +6.3% Scheduled Q4 and full-year 2025 results before market open with webcast

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Earnings-date announcements historically had positive 24-hour reactions, while RPID was down 1.9% before this headline.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

LEXINGTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2026 financial results prior to the market open on Friday, August 7, 2026.

In conjunction with the release, the Company’s management team will host a webcast conference call at 8:30 a.m. ET on Friday, August 7, 2026. The live audio webcast will be accessible on the Company’s website and can be accessed with this link. The webcast will be archived and available for replay after the event.

About Rapid Micro Biosystems

Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (“MQC”) testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct system brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered Lexington, Massachusetts and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands. For more information, please visit www.rapidmicrobio.com or follow the Company on X (formerly known as Twitter) at @rapidmicrobio or on LinkedIn



Investor Contact:
Michael Beaulieu, CFA
Vice President, Investor Relations and Corporate Communications
investors@rapidmicrobio.com

Media Contact:
media@rapidmicrobio.com

FAQ

When will Rapid Micro Biosystems (RPID) report Q2 2026 financial results?

Rapid Micro Biosystems will report its Q2 2026 financial results on Friday, August 7, 2026, before the market opens. According to the company, the release will precede an earnings webcast later that morning.

What time is the Rapid Micro Biosystems (RPID) Q2 2026 earnings conference call?

The Rapid Micro Biosystems Q2 2026 earnings conference call is scheduled for 8:30 a.m. ET on August 7, 2026. According to the company, it will be accessible as a live audio webcast via its website.

How can investors access the Rapid Micro Biosystems (RPID) Q2 2026 earnings webcast?

Investors can access the Rapid Micro Biosystems Q2 2026 earnings webcast through a live audio stream on the company’s website. According to the company, the webcast link will be available online and will later be archived for replay.

Will the Rapid Micro Biosystems (RPID) Q2 2026 earnings call be available for replay?

Yes, the Q2 2026 earnings webcast will be archived and available for replay after the event. According to Rapid Micro Biosystems, investors can access this replay via the company’s website following the live broadcast.

What is the stock symbol for Rapid Micro Biosystems ahead of its Q2 2026 earnings?

Rapid Micro Biosystems trades on Nasdaq under the stock symbol RPID. According to the company, it plans to release Q2 2026 financial results and host a webcast on August 7, 2026.

Where is Rapid Micro Biosystems headquartered as it announces Q2 2026 results?

Rapid Micro Biosystems is headquartered in Lexington, Massachusetts. According to the company, from this location it announced plans to release Q2 2026 results and hold an accompanying webcast for investors.